Gunder LC - Search Results

1

Preclinical Models of Anal Cancer Combined-Modality Therapy.

Johnson HR, Gunder LC, Gillette A, Sleiman H, Rademacher BL, Meske LM, Culberson WS, Micka JA, Favreau P, Yao E, Matkowskyj KA, Skala MC, Carchman EH. Johnson HR, et al. Among authors: gunder lc. J Surg Res. 2024 Feb;294:82-92. doi: 10.1016/j.jss.2023.09.053. Epub 2023 Oct 19. J Surg Res. 2024. PMID: 37864962 Free article.

2

PI3K/mTOR inhibition prevents anal cancer in mice with established low-grade anal dysplasia.

Gunder LC, Moyer TH, Rademacher BL, Auyueng AS, Leverson G, Zhang W, Matkowskyj KA, Carchman EH. Gunder LC, et al. Exp Mol Pathol. 2022 Apr;125:104752. doi: 10.1016/j.yexmp.2022.104752. Epub 2022 Feb 18. Exp Mol Pathol. 2022. PMID: 35183509 Free PMC article.

3

Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.

Gunder LC, Blaine-Sauer S, Johnson HR, Shin MK, Auyeung AS, Zhang W, Leverson GE, Ward-Shaw ET, King RE, McGregor SM, Matkowskyj KA, Lambert PF, Carchman EH. Gunder LC, et al. Viruses. 2022 Jul 26;14(8):1632. doi: 10.3390/v14081632. Viruses. 2022. PMID: 35893697 Free PMC article.

4

The use of a topical protease inhibitor, Saquinavir, to alleviate mouse papillomavirus-mediated anal disease.

Gunder LC, Johnson HR, Green HA, Bilger A, Moyer TH, Zhang W, Ziolkowski MR, Bertrang PA, Carchman EH. Gunder LC, et al. Virology. 2022 Nov;576:96-104. doi: 10.1016/j.virol.2022.09.012. Epub 2022 Sep 29. Virology. 2022. PMID: 36206607 Free article.

5

Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors.

Gunder LC, Moyer TH, Johnson HR, Auyeung AS, Leverson GE, Zhang W, Matkowskyj KA, Carchman EH. Gunder LC, et al. J Surg Res. 2023 Feb;282:137-146. doi: 10.1016/j.jss.2022.09.025. Epub 2022 Oct 20. J Surg Res. 2023. PMID: 36274448

6

The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice.

Johnson HR, Gunder LC, Leverson GE, Carchman EH. Johnson HR, et al. Among authors: gunder lc. Dis Colon Rectum. 2023 Mar 1;66(3):360-365. doi: 10.1097/DCR.0000000000002623. Epub 2023 Jan 4. Dis Colon Rectum. 2023. PMID: 36599112 Free PMC article.

7

Systemic Delivery of a Dual PI3K/mTOR Inhibitor More Effective than Topical Delivery in Preventing Anal Carcinogenesis in an HPV Transgenic Mouse Model.

Gunder LC, Moyer TH, Ziolkowski MR, Keating MK, Leverson GE, Zhang W, Carchman EH. Gunder LC, et al. J Cancer Sci Clin Ther. 2022;6(2):157-173. doi: 10.26502/jcsct.5079153. Epub 2022 Apr 18. J Cancer Sci Clin Ther. 2022. PMID: 36683775 Free PMC article.

8

Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.

Gunder LC, Johnson HR, Yao E, Moyer TH, Green HA, Sherer N, Zhang W, Carchman EH. Gunder LC, et al. Viruses. 2023 Apr 20;15(4):1013. doi: 10.3390/v15041013. Viruses. 2023. PMID: 37112993 Free PMC article.

9

Topical Protease Inhibitor Increases Tumor-Free and Overall Survival in CD4-Depleted Mouse Model of Anal Cancer.

Yao E, Gunder L, Moyer T, Matkowskyj KA, Fox K, Zhou Y, Haggerty S, Johnson H, Sherer N, Carchman E. Yao E, et al. Viruses. 2024 Sep 5;16(9):1421. doi: 10.3390/v16091421. Viruses. 2024. PMID: 39339897 Free PMC article.

10

Obesity Augments Glucocorticoid-Dependent Muscle Atrophy in Male C57BL/6J Mice.

Gunder LC, Harvey I, Redd JR, Davis CS, Al-Tamimi A, Brooks SV, Bridges D. Gunder LC, et al. Biomedicines. 2020 Oct 15;8(10):420. doi: 10.3390/biomedicines8100420. Biomedicines. 2020. PMID: 33076257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters